Table 3.

Comparison of selected markers levels in patients who developed CI-AKI and those who did not

Biomarker	Time (h)	Group of patients who developed CI-AKI	Group of patients who did not develop CI-AKI	p value
NGAL (ng/mL)	0	164.8 (136.2–309.3)	157.9 (92.4–220.2)	0.52
	24	213.6 (85.0–362.5)	208.0 (157.8–299.9)	0.44
	72	192.7 (83.5–289.8)	118.5 (73.4–173.9)	0.25
KIM-1 (pg/mL)	0	113.0 (47.9–365.9)	70.2 (62.4–311.2)	0.95
	24	232.6 (98.1–503.9)	103.7 (42.4–341.9)	0.07
	72	118.5 (74.0–157.1)	90.3 (34.3–420.4)	0.89
L-FABP (ng/mL)	0	3.7 (1.8–5.3)	4.7 (2.9–5.0)	0.98
	24	4.5 (3.2–5.5)	4.8 (2.7–5.3)	0.37
	72	5.0 (3.7–5.4)	4.6 (3.0–5.4)	0.79
IL-18 (pg/mL)	0	291.3 (271.5–380.6)	261.6 (236.8–353.3)	0.58
	24	340.9 (326.0–427.7)	264.1 (219.4–350.8)	0.05
	72	316.1 (291.3–358.3)	251.4 (244.2–328.5)	0.38

Bolded value indicate statistical significance